Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
55.71
-1.28 (-2.25%)
Mar 9, 2026, 3:04 PM CST
SHE:300049 Market Cap
SHE:300049 has a market cap or net worth of 14.76 billion as of March 9, 2026. Its market cap has increased by 54.16% in one year.
Market Cap
14.76B
Enterprise Value
14.56B
Revenue
1.47B
Ranking
n/a
PE Ratio
118.57
Stock Price
55.71
Market Cap Chart
Since January 20, 2010, SHE:300049's market cap has increased from 2.54B to 14.76B, an increase of 481.76%. That is a compound annual growth rate of 11.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 14.76B | -20.88% |
| Dec 31, 2025 | 18.66B | 122.08% |
| Dec 31, 2024 | 8.40B | -26.74% |
| Dec 29, 2023 | 11.47B | 78.43% |
| Dec 30, 2022 | 6.43B | 70.55% |
| Dec 31, 2021 | 3.77B | 80.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 17.76B |
| BrightGene Bio-Medical Technology | 17.30B |
| Jinyu Bio-technology | 16.34B |
| Anhui Anke Biotechnology (Group) | 16.07B |
| Tibet Cheezheng Tibetan Medicine | 14.22B |
| Vcanbio Cell & Gene Engineering Corp., | 14.09B |
| Mabwell (Shanghai) Bioscience | 13.66B |
| Pacific Shuanglin Bio-pharmacy | 13.33B |